UC BON.CAP.CERT. 12/24 AMD/ DE000HD7ZMD8 /
2024-11-12 7:45:10 PM | Chg.-0.680 | Bid9:00:21 PM | Ask9:00:21 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
178.860EUR | -0.38% | 179.120 Bid Size: 400 |
179.140 Ask Size: 400 |
ADVANCED MIC.DEV. D... | - - | 2024-12-31 | Call |
GlobeNewswire
09-01
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire
08-27
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire
08-27
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
08-26
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...
GlobeNewswire
08-23
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular ...